Cognex Corp: Form 10-Q for the period ended Oct 2, 2016
Filed with the SEC on Oct 31, 2016 and accepted by EDGAR at Oct 31, 2016, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-10-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-07-04 to 2016-10-02 | $148.0m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2016-01-01 to 2016-10-02 | $391.4m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2016-07-04 to 2016-10-02 | $32.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2016-01-01 to 2016-10-02 | $88.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2016-07-04 to 2016-10-02 | $115.2m | us-gaap:GrossProfit |
| Gross profit | 9 months2016-01-01 to 2016-10-02 | $302.5m | us-gaap:GrossProfit |
| Research and development | 3 months2016-07-04 to 2016-10-02 | $18.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2016-01-01 to 2016-10-02 | $58.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2016-07-04 to 2016-10-02 | $42.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2016-01-01 to 2016-10-02 | $123.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-07-04 to 2016-10-02 | $54.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-01-01 to 2016-10-02 | $120.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2016-07-04 to 2016-10-02 | $2.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-01-01 to 2016-10-02 | $14.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-07-04 to 2016-10-02 | $53.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-01-01 to 2016-10-02 | $111.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-07-04 to 2016-10-02 | $0.61 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2016-01-01 to 2016-10-02 | $1.28 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-07-04 to 2016-10-02 | $0.63 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2016-01-01 to 2016-10-02 | $1.31 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-07-04 to 2016-10-02 | 87,346,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2016-01-01 to 2016-10-02 | 86,805,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2016-01-01 to 2016-10-02 | $106.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2016-01-01 to 2016-10-02 | $10.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2016-01-01 to 2016-10-02 | $18.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2016-01-01 to 2016-10-02 | $18.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2016-10-02 | $61.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-10-02 | $530.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-10-02 | $1.02bn | us-gaap:Assets |
| Current liabilities | At period end2016-10-02 | $69.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-10-02 | $76.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-10-02 | $943.9m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2016-10-02 | 85,665,974 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000851205-16-000038. Last ingested by Listed: Nov 10, 2026, 23:02 ET. Listed shows no prices and gives no investment advice.